Impact of complications after surgery for colorectal liver metastasis on patient survival

Journal of Surgical Research

Volumn 164, Issue 1, 2010, Pages

  Schepers, Abbey ^a   Mieog, Sven ^a   Van De Burg, Boudewijn Borger ^a   Van Schaik, Jan ^a   Liefers, Gerrit Jan ^a   Marang Van De Mheen, Perla J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

colorectal cancer; complications; hepatic resection; isolated hepatic perfusion; liver metastases; liver surgery; survival

Indexed keywords

ABSCESS; ADULT; ALLERGIC REACTION; ARTICLE; ASCITES; ATELECTASIS; BILE LEAKAGE; BLEEDING; COLORECTAL CANCER; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DECUBITUS; DELIRIUM; DIABETES INSIPIDUS; EDEMA; ELECTROLYTE DISTURBANCE; FEMALE; FOLLOW UP; GUIDE WIRE; HEART ARRHYTHMIA; HEART FAILURE; HEMATOMA; HEMATOTHORAX; HEMOPTYSIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; ILEUS; INTESTINAL BLEEDING; INTESTINE PERFORATION; KIDNEY FAILURE; LEUKOPENIA; LIVER DYSFUNCTION; LIVER FAILURE; LIVER METASTASIS; LIVER PERFUSION; LIVER RESECTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALAISE; MALE; MEDICAL RECORD REVIEW; MULTIPLE ORGAN FAILURE; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPSIS; SURGICAL MORTALITY; SURVIVAL TIME; THROMBOCYTOPENIA; THROMBOSIS; URINARY TRACT INFECTION; URINE RETENTION; VEIN OCCLUSION; WOUND INFECTION;

CATHETER ABLATION; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 77958112420     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2010.07.022     Document Type: Article

References (24)

1. D.C. McMillan, and C.S. McArdle Epidemiology of colorectal liver metastases Surg Oncol 16 2007 3
2. T. Ruers, and R.P. Bleichrodt Treatment of liver metastases, an update on the possibilities and results Eur J Cancer 38 2002 1023
3. J. Scheele, R. Stang, and A. Altendorf-Hofmann Resection of colorectal liver metastases World J Surg 19 1995 59
4. J. Rothbarth, R.A.E.M. Tollenaar, and J.H.M. Schellens Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: Recent trends and perspectives Eur J Cancer 40 2004 1812
5. J. Rothbarth, M.E.J. Pijl, and A.L. Vahrmeijer Isolated hepatic perfusion with high dose melphalan for the treatment of colorectal metastasis confined to the liver Br J Surg 90 2003 1391
6. American Society of Anesthesiologists New classification of physical status Anesthesiology 24 1963 111
7. P.J. Marang-van de Mheen, M.C. Stadlander, and J. Kievit Adverse outcomes in surgical patients. Implementation of a nationwide routine reporting system Qual Saf Health Care 15 2006 320
8. P.J. Marang-van de Mheen, N. van Hanegem, and J. Kievit Effectiveness of routine reporting to identify minor and serious adverse outcomes in surgical patients Qual Saf Health Care 14 2005 378
9. J. Kievit, J. Jeekel, and F.B.M. Sanders Adverse outcome reporting and quality improvement (in Dutch) Med Contact 54 1999 1363
10. T.A. Brennan, L.L. Leape, and N.M. Laird Incidence of adverse outcomes and negligence in hospitalized patients: Results of the Harvard Medical Practice Study I N Engl J Med 324 1991 370
11. A.A. Gawande, E.J. Thomas, and M.J. Zinner The incidence and nature of surgical adverse outcomes in Colorado en Utah in 1992 Surgery 126 1999 66
12. A.K. Kable, R.W. Gibberd, and A.D. Spigelman Adverse outcomes in surgical patients in Australia Int J Qual Hlth Care 14 2002 269
13. Davis P, Ley-Yee R, Briant R, et al. Adverse outcomes in New Zealand Public Hospitals: Principal findings from a national survey. Occasional paper no. 3. New Zealand: Ministry of Health, December 2001.
14. L.B.J. Van Iersel, H. Gelderblom, and A.L. Vahrmeijer Isolated hepatic melphalan perfusion of colorectal liver metastases: Outcome and prognostic factors in 154 patients Ann Oncol 19 2008 1127
15. L.B.J. Van Iersel, M.R. Verlaan, and A.L. Vahrmeijer Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacological evaluation Eur J Surg Oncol 33 2007 874
16. Veltkamp SC. Complications in surgery (PhD thesis). Utrecht, november 2001
17. P. Michel, J.L. Quenon, and A.M. Sarasqueta Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals BMJ 328 2004 199
18. Colorectal Cancer Collaborative Group Palliative chemotherapy for advanced colorectal cancer: Systematic review and meta-analysis BMJ 321 2000 531
19. T.J. Hobday, S. Cha, and T. Buroker Long term survivors (LTS) of metastatic colorectal cancer (MCRC) treated with chemotherapy only: A North Central Cancer Treatment Group (NCCTG) review (abstract) Proc Am Soc Clin Oncol 21 2002 174a
20. H.K. Sanoff, D.J. Sargent, and M.E. Campbell Five-year data and prognostic factor analysis of Oxaliplatin and Irinotecan combinations for advanced colorectal cancer: N9741 J Clin Oncol 26 2008 5721
21. G.D. Leonard, B. Brenner, and N.E. Kemeny Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma J Clin Oncol 23 2005 2038
22. S.R. Alberts, W.L. Horvath, and W.C. Sternfeld Oxaliplatin, Fluorouracil, and Leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II Study J Clin Oncol 23 2005 9243
23. R. Adam, D.A. Wicherts, and R.J. de Haas Patients with initially unresectable colorectal liver metastases: Is there a possibility of cure? J Clin Oncol 27 2009 1829
24. C. Barone, G. Nuzzo, and A. Cassano Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases Br J Cancer 97 2007 1035